VEGF and the Fab fragment of a humanized neutralizing antibody: Crystal structure of the complex at 2.4 Å resolution and mutational analysis of the interface

Structure

Volumn 6, Issue 9, 1998, Pages 1153-1167

  Muller, Yves A ^a,b   Chen, Yvonne ^a   Christinger, Hans W ^a   Li, Bing ^a   Cunningham, Brian C ^a   Lowman, Henry B ^a   De Vos, Abraham M ^a  

^a GENENTECH INC   (United States)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Angiogenesis; Antibody antigen recognition; Mutagenesis; Phage display; X ray structure

Indexed keywords

MURINAE;

EID: 0032530717     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-2126(98)00116-6     Document Type: Article

References (57)

1. Dvorak, H.F., Brown, L.F., Detmar, M. & Dvorak, A.M. (1995). Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability and angiogenesis. Am. J. Pathol. 146, 1029-1039.
2. Ferrara, N. (1995). The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Res. Treat. 36, 127-137.
3. Folkman, J. (1995). Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1, 27-31.
4. Carmeliet, P., et al., & Nagy, A. (1996). Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435-439.
5. Ferrara, N., et al., & Moore, M.W. (1996). Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439-442.
6. Kim, K.J., et al., & Ferrara, N. (1993). Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362, 841-844.
7. Baca, M., Presta, L.G., O'Connor, S.J. & Wells, J.A. (1997). Antibody humanization using monovalent phage display. J. Biol. Chem. 272, 10678-10684.
8. Presta, L.G, et al., & Ferrara, N. (1997). Humanization of an antivascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Res. 47, 4593-4599.
9. Waltenberger, J., Claesson-Welsh, L., Siegbahn, A., Shibuya, M. & Heldin, C.-H. (1994). Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J. Biol. Chem. 269, 26988-26995.
10. Houck, K.A., Ferrara, N., Winer, J., Cachianes, G., Li, B. & Leung, D.W. (1991). The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol. Endocrinol. 5, 1806-1814.
11. Keyt, B.A., et al., & Ferrara, N. (1996). The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency. J. Biol. Chem. 271, 7788-7795.
12. Muller, Y.A., Christinger, H.W., Keyt, B.A. & De Vos, A.M. (1997). The crystal structure of vascular endothelial growth factor (VEGF) refined to 1.93 Å resolution: multiple copy flexibility and receptor binding. Structure 5, 1325-1338.
13. Sun, P.D. & Davies, D.R. (1995). The cystine-knot growth-factor superfamily. Annu. Rev. Biophys. Biomol. Struct. 24, 269-291.
14. Keyt, B.A., et al., & Ferrara, N. (1996). Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. J. Biol. Chem. 271, 5638-5646.
15. Muller, Y.A., Li, B., Christinger, H.W., Wells, J.A., Cunningham, B.C. & De Vos, A.M. (1997). Vascular endothelial growth factor: crystal structure and functional mapping of the kinase domain receptor binding site. Proc. Natl Acad. Sci. USA 94, 7192-7197.
16. Wiesmann, C., Fuh, G., Christinger, H.W., Eigenbrot, C., Wells, J.A. & De Vos, A.M. (1997). Crystal structure at 1.7 Å resolution of VEGF in complex with domain 2 of the Flt-1 receptor. Cell 91, 695-704.
17. Cunningham, B.C. & Wells, J.A. (1989). High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis. Science 244, 1081-1085.
18. Kelley, R.F. & O'Connell, M.P. (1993). Thermodynamic analysis of an antibody functional epitope. Biochemistry 32, 6828-6835.
19. Wells, J.A. & De Vos, A.M. (1996). Hematopoietic receptor complexes. Annu. Rev. Biochem. 65, 609-634.
20. Christinger, H.W., et al., & De Vos, A.M. (1996). Crystallization of the receptor binding domain of vascular endothelial growth factor. Proteins 26, 353-357.
21. Read, R.J. (1986). Improved Fourier coefficients for maps using partial structures with errors. Acta Cryst. A 42, 140-149.
22. Laskowski, R.A., MacArthur, M.W., Moss, D.S. & Thornton, J.M. (1993). Procheck: a program to check the stereochemical quality of protein structures. J. Appl. Cryst. 26, 283-291.
23. Sogabe, S., et al., & Robinson, J.A. (1997). Neutralizing epitopes on the extracellular interferon γ receptor (IFNγR) α-chain characterized by homolog scanning mutagenesis and x-ray crystal structure of the A6 FAB-IFNγR1-108 complex. J. Mol. Biol. 273, 882-897.
24. Hoffman, D.W., Cameron, C.S., Davies, C., White, S.W. & Ramakrishnan, V. (1996). Ribosomal protein L9: a structure determination by the combined use of x-ray crystallography and NMR spectroscopy. J. Mol. Biol. 264, 1058-1071.
25. Oefner, C., D'Arcy, A., Winkler, F.K., Eggimann, B. & Hosang, M. (1992). Crystal structure of human platelet-derived growth factor BB. EMBO J. 11, 3921-3926.
26. HER2 antibody for human cancer therapy. Proc. Natl Acad. Sci. USA 89, 4285-4289.
27. HER2 antibody 4D5 and comparison with molecular modelling. J. Mol. Biol. 229, 969-995.
28. Wilson, I.A. & Stanfield, R.L. (1994). Antibody-antigen interactions: new structures and new conformational changes. Curr. Opin. Struct. Biol. 4, 857-867.
29. Chothia, C., et al., & Poljak, R.J. (1989). Conformations of immunoglobulin hypervariable regions. Nature 342, 877-883.
30. Bossart-Whitaker, P., Chang, C.Y.Y., Novotny, J., Benjamin, D.C. & Sheriff, S. (1995). The crystal structure of the antibody N10-Staphylococcal nuclease complex at 2.9 Å resolution. J. Mol. Biol. 253, 559-575.
31. Chacko, S., et al., & Sheriff, S. (1996). Refined structures of bobwhite quail lysozyme uncomplexed and complexed with the HyHEL-5 FAB fragment. Proteins 26, 55-65.
32. Davies, D.R. & Cohen, G.H. (1996). Interactions of protein antigens with antibodies. Proc. Natl Acad. Sci. USA 93, 7-12.
33. Jones, S. & Thornton, J.M. (1996). Principles of protein-protein interactions. Proc. Natl Acad. Sci. USA 93, 13-20.
34. Wilson, I.A. & Stanfield, R.L. (1993). Antibody-antigen interactions. Curr. Opin. Struct. Biol. 3, 113-118.
35. Wilmot, C.M. & Thornton, J.M. (1988). Analysis and prediction of the different types of β-turn in proteins. J. Mol. Biol. 203, 221-232.
36. Padlan, E.A. (1990). On the nature of antibody combining sites: unusual structural features that may confer on these sites an enhanced capacity for binding ligands. Proteins 7, 112-124.
37. Cunningham, B.C. & Wells, J.A. (1993). Comparison of a structural and a functional epitope. J. Mol. Biol. 234, 554-563.
38. Novotny, J., Bruccoleri, R.E. & Saul, F.A. (1989). On the attribution of binding energy in antigen-antibody complexes McPC 603, D1-3, and HyHEL-5. Biochemistry 28, 4735-4749.
39. Amit, A.G., Mariuzza, R.A., Phillips, S.E.V. & Poljak, R.J. (1986). Three-dimensional structure of an antigen-antibody complex at 2.8 Å resolution. Science 233, 747-753.
40. Clackson, T., Ultsch, M.H., Wells, J.A. & De Vos, A.M. (1998). Structural and functional analysis of the 1:1 growth hormone:receptor complex reveals the molecular basis for receptor affinity. J. Mol. Biol. 277, 1111-1128.
41. De Vos, A.M., Ultsch, M. & Kossiakoff, A.A. (1992). Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 225, 306-312.
42. Clackson, T. & Wells, J.A. (1995). A hot spot of binding energy in a hormone-receptor interface. Science 267, 383-386.
43. Banner, D.W., et al., & Kirchhofer, D. (1996). The crystal structure of the complex of blood coagulation factor Vila with soluble tissue factor. Nature 380, 41-46.
44. Kelley, R.F., Costas, K.E., O'Connell, M.P. & Lazarus, R.A. (1995). Analysis of the factor Vila binding site on human tissue factor: effects of tissue factor mutations on the kinetics and thermodynamics of binding. Biochemistry 34, 10383-10392.
45. Mariuzza, R.A. & Poljak, R.J. (1993). The basics of binding: mechanisms of antigen recognition and mimicry by antibodies. Curr. Opin. Immunol. 5, 50-55.
46. Webster, D.M., Henry, A.H. & Rees, A.R. (1994). Antibody-antigen interactions. Curr. Opin. Struct. Biol. 4, 123-129.
47. Otwinowski, Z. (1993). Oscillation Data Reduction Program. In Proceedings of the CCP4 Study Weekend: Data Collection and Processing. (Sawyer, L., Isaacs, N. & Bailey, S. eds). pp. 56-62, SERC Daresbury Laboratory, UK.
48. Brünger, AT. (1990). Extension of molecular replacement: a new search strategy based on Patterson correlation refinement. Acta Cryst. A 46, 46-57.
49. Brünger, AT., Kuriyan, J. & Karplus, M. (1987). Crystallographic R factor refinement by molecular dynamics. Science 235, 458-460.
50. CCP4 (1994). The CCP4 suite: Programs for protein crystallography. Acta Cryst. D 50, 760-763.
51. Jones, T.A., Zou, J.-Y., Cowan, S.W. & Kjeldgaard, M. (1991). Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Cryst. A 47, 110-119.
52. Kunkel, T.A., Bebenek, K. & McClary, J. (1991). Efficient site-directed mutagenesis using uracil-containing DNA. Methods Enzymol. 204, 125-139.
53. Lowman, H.B. (1998). Phage display of peptide libraries on protein scaffolds. In Methods in Molecular Biology, vol. 87: Combinatorial Peptide Library Protocols. (Cabilly,S., ed.). pp. 249-264, Humana Press, Totowa, NJ, USA.
54. Karlsson, R., Michaelsson, A. & Mattson, A. (1991). Kinetic analysis of monoclonal antibody-antigen interactions with a new biosensor based analytical system J. Immunol. Methods 145, 229-240.
55. Nicholls, A., Bharadwaj, R. & Honig, B. (1993). GRASP: graphical representation and analysis of surface properties. Biophys. J. 64, 166-170.
56. Kabat, E.A., Wu, T.T., Redi-Miller, M., Perry, H.M. & Gottesman, K.S. (1987). Sequences of Proteins of Immunological Interest, 4th Edition. National Institute of Health, Bethesda, MD, USA.
57. Browner, M.F., Fauman, E.B. & Fletterick, R.J. (1992). Tracking conformational states in allosteric transitions of phosphorylase. Biochemistry 31, 11297-11304.